In pancreatic ductal carcinoma, interleukin (IL)-17 is highly expressed, and its recruitment of neutrophils triggers NETs to promote tumor multidrug resistance26. The gene discussed is IL17A; the disease is pancreatic ductal adenocarcinoma.